ICON experts frequently author or contribute to industry trade press. The following are some recent articles.
Why Sites Matter
PMG Research contributes to this article on investigative sites and the drug development process.
Adaptive Designs for Clinical Trials
adaptive design for clinical trials and how it can improve speed to market.
Adaptive designs patient value
Adaptive design and patient value
The Patient Data Gold Rush
Tom O'Leary's presented to the Financial Times Digital Health Summit Europe regarding the use of technology to mine the clinical data patient.
Bring Your Own Device for Trial Outcome Assessment
A research survey to identify and assess the perceived barriers and challenges with the use of BYOD for eCOA in clinical trials.
Countermeasures to Oncology Trial Failure: 5 Smarter Approaches to Trial Design and Analysis
Countermeasures to Oncology Trial Failures.
CRO Industry Update
Just as drug products have become increasingly complex, regulatory and payer demands have added complexities and costs to drug development.
Postmarket Surveillance and M&A
Vicki Anastasi discusses how a merger or acquisition can impact your medical device’s postmarket surveillance strategy.
What Errors Do We Miss in Clinical Trials
Examining the deficits in current risk mitigation approaches.
5 Things to Know About ICH GCP (R2) 2016
The rising risk of errors, particularly those with complex sources that may be difficult to ascertain in large organizations.